Texas A&M scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing ...

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast ...

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive ...

Kasturba Medical College, Mangaluru, has entered into a Memorandum of Understanding (MoU) with BEBIG Medical GmbH, which deals with brachytherapy systems and technologies, to establish a Centre for ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

Experts explore a novel combined therapy for liver-dominant neuroendocrine tumors, enhancing treatment durability with chemotherapy and PRRT. In an interview with Targeted Oncology at the 2025 North ...

A novel treatment combining chemotherapy and PRRT shows promising safety and efficacy for neuroendocrine tumors, with high response rates and ongoing trials. Michael Soulen, MD, spoke to Targeted ...

According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...

Cancer care at Ridley-Tree has always been built on a simple but powerful idea: nearly everything a patient needs should exist under one roof.

If you’ve been diagnosed with breast cancer, you’re likely wondering if it has spread and if so, how far? Your doctor can ...

PTCOG president Marco Durante describes an exciting future for the technology and shares his vision for closer international ...

A thymoma diagnosis can feel overwhelming, but it is important to know that many patients respond well to treatment.